Roche Holding AG-Genusschein
13F holders, Q1 2025 (March 31)3holders
0new positions
0sold out
$328.35avg. 13F price*
At the end of Q1 2025, 3 institutions reported holding Roche Holding AG-Genusschein in their 13F filings, unchanged from Q4 2024. 0 opened new positions and 0 sold out. The largest holders were Aristotle Capital Management, LLC ($75.5M), Boston Common Asset Management, LLC ($16.7M) and Generali Investments CEE, investicni spolecnost, a.s. ($2.4M).
- Company
- Roche Holding AG-Genusschein
- CUSIP
- H69293217
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 1,362 shares bought and 10,561 shares sold, net −9,199 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Aristotle Capital Management, LLC | 0.15% | Reduce -4.0% | 230,001 | $75.5M |
| Boston Common Asset Management, LLC | 0.51% | Add +2.8% | 50,791 | $16.7M |
| Generali Investments CEE, investicni spolecnost, a.s. | 0.23% | Reduce -12.9% | 7,403 | $2.4M |
"% of holder's portfolio" is ROCHE HOLDING AG-GENUSSCHEIN's weight in each manager's 13F, not the share of Roche Holding AG-Genusschein the manager owns.